The history of Viagra and its originator, copyright, presents a fascinating picture for prospective investors. While the iconic drug initially produced enormous profits , its exclusivity has lapsed , leading to generic versions flooding the arena. This decline in cost presents a real hurdle for copyright and any portfolio considering a heavy positi